{
  "id": 14462980,
  "title": "DR Congo Ebola vaccine trial to begin within weeks: WHO",
  "url": "https://urgent.news/2026/10/14/dr-congo-ebola-vaccine-trial-to-begin-within-weeks-who-14462980",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-14T13:22:29.000Z",
  "source": {
    "name": "The Hindu Health",
    "slug": "the-hindu-health",
    "url": "https://www.thehindu.com/sci-tech/health/dr-congo-ebola-vaccine-trial-to-begin-within-weeks-who/article71583980.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will go through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Medical Xpress",
        "title": "DR Congo Ebola vaccine trial to begin within weeks: WHO",
        "url": "https://urgent.news/2026/10/14/dr-congo-ebola-vaccine-trial-to-begin-within-weeks-who",
        "published": "2026-10-14T09:20:01.000Z"
      },
      {
        "outlet": "The Hindu - Sci-Tech",
        "title": "DR Congo Ebola vaccine trial to begin within weeks: WHO",
        "url": "https://urgent.news/2026/10/14/dr-congo-ebola-vaccine-trial-to-begin-within-weeks-who-14460272",
        "published": "2026-10-14T13:22:29.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}